Comparison of efficacy between levosalbutamol and levosalbutamol-ipratropum nebulization in mild to moderate childhood asthma


  • R. Ramanathan Department of Pediatrics, Rajah Muthiah Medical College and Hospital, Chidambaram, Tamil Nadu, India
  • B. Mahalakshmi Department of Pediatrics, Rajah Muthiah Medical College and Hospital, Chidambaram, Tamil Nadu, India



Ipratropium bromide, Levosalbutamol, Peak expiratory flow rate, Pulmonary asthma score


Background: The objective of the study was to compare the efficacy between levosalbutamol and ipratropium combination over levosalbutamol nebulisation in reversing airflow obstruction and improve oxygenation, evaluated using the pulmonary asthma score, SaO2, and PEFR in mild and moderate asthma.

Methods: A prospective, randomized, study was performed in RMMCH pediatric emergency department. Children between 6 and 12 years of age who presented with mild to moderate asthma exacerberations were enrolled in the study. They were randomly allocated into two different groups: one nebulised with levosalbutamol alone and another with addition of ipratropium bromide to levosalbutamol. Baseline Peak expiratory flow rate and Final absolute values or change from baseline 60-120 minutes after the inhalation are measured. Patients were evaluated using the pulmonary score.

Results: After treatment there is improvement in the mean pulmonary asthma scores and PEFR percentage in A+B group than A group, but it is not statistically significant (p value >0.05). There is statistically significant improvement in pulmonary asthma score and PEFR in each of the groups after nebulisation and pulmonary asthma score has a sensitivity of 66.7% and 65.6% in diagnosing severity of asthma in relation to PEFR.


From the Global strategy for the diagnosis and management of Asthma in Children 5 years and younger, Global initiative for Asthma. GINA; 2009. Available at: (Accessed 18 May 2011).

Bloomberg GR. The exacerbation component of impairment and risk in pediatric asthma. Curr Opin Allergy Clin Immunol. 2010;10(2):155-60.

Guttmann A, Zagorski B, Austin PC, Schull M, Razzaq A, To T, et al. Effectiveness of emergency department asthma management strategies on return visits in Children: A pediatric population based study. Pediat. 2007 Dec 1;120(6):e1402-10.

Rosychuk RJ, Voklander DC, klassen TP, Senthilselvan A, Marrie TJ, Rowe BH. Asthma presentations by children to emergency departments in a Canadian providence; A population based study. Pediatr Pulmonol. 2010;45(10):985-92.

Cunningham S, Logan C, Lockerbie L, Dunn MJ, McMurray A, Prescott RJ. Effect off an integrated care pathway on acute asthma/wheeze in children attending hospital, Cluster randomized trial. J Pediatr. 2008;152(3):315-20.

British medical association. Asthma: a follow up statement from an international pediatric asthma group. Arch Dis Child. 1992;67:240-8.

Ernst P, Fitzgerald JM, Spier S. Canadian asthma consensus conference summary of recommendations. Can Respir J. 1996;3(2):89-101.

Werner HA. Status asthmaticus in children. Chest 2001;119:1913-29.

Tal A, Levy N, Bearman JE. Methyl prednisolone therapy for acute asthma in infants and toddlers:a controlled clinical trial. Pediat. 1990 Sep 1;86(3):350-6.

Scarfone RJ, Fuchs SM, Nager AL, Shane SA. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatr. 1993 Oct 1;92(4):513-8.

Svedmyr N. Fenoterol: A beta 2 agonists for use in asthma pharmacology and pharmacokinetics, clinical efficacy and adverse effects. Pharmacotherapy: J Huma Pharmacol Drug Ther. 1985 May 6;5(3):109-26.

Sears MR. Clinical application of beta agonists, practical allergy Immunol. 1992;7:98-100.

Gross NJ. Ipratropium bromide. N Engl J Med. 1988 Aug 25;319(8):486-94.

Chapman K. An international perspective on anticholinergic therapy. Am J Med. 1996 Jan 29;100:S2-4.

Guill MF, Maloney MJ, Durant RH. Comparison of inhaled metaproterenol, inhaled atropine sulfate, and their combination in treatment of children with acute asthma Ann Allergy. 1987 Nov;59(5):367-71.

Watson WTA Becker AB, Simsons FER Comparison of ipratropium solution, F Eneterol solution, and their combination administered by nebulizer and face mask to children with acute asthma. J allergy Clin Immunol. 1988 Dec 1;82(6):1012-8.

Ossmand MH Klassen TP. Efficacy of ipratropium in acute childhood asthma a meta analysis. Acad Emerg Med. 1995 Jul;2(7):651-6.

Smith SR, Baty JD, Hodge DIII. Validation of the pulmonary score: an asthma severity score for children. Acad Emerg Med. 2002 Feb;9(2):99-104.

Fuhlbrigge AL, Weiss ST Kuntz KM, David Paltiel A. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma. Pediatrics. 2006 Aug 1;118(2):e347-55.

MAKING SENSE of Lung Function Tests. Second edition. A hands-on guide Jonathan Dakin, MD FRCP BSc Hons, UK Mark Mottershaw, BSc Hons MSc, UK Elena Kourteli, FRCA, UK 2nd ed, Boca Raton, United Kingdom; 2017:224.

Quershi F, Pestian J, Davis P, Zaritsky A. Effect of nnebulized ipratropium on the hospitalization rates of children with asthma. N Eng J Med. 1998 Oct 8;339(15):1030-5.

Schuh S. Efficacy of frequent nebulised ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. J Pediatr. 1995 Apr 1;126(4):639-45.

Sharma A, Madaan A.nebulised salbutamol Vs salbutamol and ipratropium combination in asthma. Indian J pediatr. 2004 Feb 1;71(2):121-4.

Iramain R, López-Herce J, Coronel J, Spitters C, Guggiari J, Bogado N. Inhaled salbutamol plus ipratropium in moderate and severe asthma crises in children. J Asthma. 2011 Apr 1;48(3):298-303.

Ducharme FM, Davis GM. Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma. J Pediat. 1998 Oct 1;133(4):479-85.

Zorc JJ, Pusic MV, Ogborn CJ, Lebet R, Duggan AK. Ipratropium bromide added to asthma treatment in the pediatric emergency department. Pediatrics. 1999 Apr 1;103(4):748-52.






Original Research Articles